Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have recently been diagnosed with stage I, II, or III breast cancer
- People whose treatment plan includes therapies that can affect the heart, such as certain chemotherapy drugs (anthracyclines), targeted therapies, or radiotherapy
- People who have signed a form giving their informed consent to take part
- People who have received medical approval to participate in the trial
- People who are able to use a smartphone at a basic level
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have previously received cancer treatment
- People who have previously been diagnosed with cancer
- People who are pregnant, or people who are already doing structured therapeutic exercise at the time of diagnosis and are doing 150 minutes or more of moderate-intensity exercise, or 75 minutes or more of vigorous-intensity exercise, per day
- People for whom therapeutic exercise is not recommended due to psychiatric or cognitive conditions, or due to a serious ongoing health condition that prevents exercise (such as advanced lung disease, a need for supplemental oxygen, significant narrowing of an artery, the spread of cancer to other parts of the body, or similar conditions)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Irene Cantarero Villanueva, PhD, Universidad de Granada
Phone: 637007250
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cardiotoxicity; Systolic function
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.